New Square Capital LLC Biogen Inc. Transaction History

New Square Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $2,026 - $2,287	-8 Reduced 72.73%	3 $0
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $513 - $584	-2 Reduced 15.38%	11 $3,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $2,271 - $2,760	9 Added 225.0%	13 $3,000
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $775 - $976	4 New	4 $1,000
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $4,016 - $6,045	-17 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $11,649 - $13,451	-44 Reduced 72.13%	17 $5,000
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $4,570 - $5,797	17 Added 38.64%	61 $19,000
Q1 2018 Apr 24, 2018	SELL	$260.13 - $367.91 $10,405 - $14,716	-40 Reduced 47.62%	44 $12,000
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $23,616 - $27,693	84	84 $26,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.